ScienceDex / Researcher record
Oster, Wolfgang
- Oncoceutics, Inc. (no department on record)
From the FY2018 NIH awards this investigator leads as contact PI. The department is the award's.
- R01 Holder
- Early Career
NIH Funding · FY2018
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2015 | $1,057,452 | 2 | #6,443 |
| 2016 | $802,499 | 2 | #9,019 |
| 2017 | $448,700 | 2 | #18,124 |
| 2018 | $2,214,318 | 4 | #2,429 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20152 records
- FY20162 records
- FY20172 records
- FY2018 · selected4 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2015 through FY2018Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2018 award records by amount
NIH award records listing Oster, Wolfgang as a PI. Multi-PI records show the full award amount for context.
- 2R44CA192427-04R44Contact PIAdaptive Clinical Efficacy Evaluation of ONC201 in Recurrent High Grade Glioma$999.6Kaward amount
- 4R44CA221398-02R44Contact PIClinical Efficacy Evaluation of First-in-class Imipridone ONC201 in Recurrent Type II Endometrial Cancer$714Kaward amount
- 5R01FD005402-02R01Contact PIPhase I/II Trial of ONC201 for the Treatment of Multiple Myeloma IND121,496 (01/05/2015)$496.4Kaward amount
- 3R44CA221398-01S1R44Contact PIClinical Efficacy Evaluation of First-in-class Imipridone ONC201 in Recurrent Type II Endometrial Cancer$4.3Kaward amount
Award organization
Organizations that administered FY2018 awards listing Oster, Wolfgang as a PI.
FY2018 award administered by Oncoceutics, Inc. ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2015First NIH AwardOncoceutics, Inc.
- 2015$500K Cumulative Funding
- 2015$1M Cumulative Funding
- 2015Entered Top 50% NationallyRanked #6443
- 2016R01 Grant Holder
- 2017$2M Cumulative Funding
- 2018Entered Top 25% NationallyRanked #2429